The success of any harm reduction intervention is dependent on two factors: its potential to reduce the risks associated with a particular activity and the number of people who adopt the intervention.
"Harm reduction is a strategy used in medicine and social policy to minimize harm to individuals and/or wider society from hazardous behaviors or practices that cannot be completely avoided or prevented.” (“Nicotine Without Smoke”, Royal College of Physicians, 2016)
While non-combusted tobacco products and e-cigarettes drastically reduce the exposure to known harmful constituents in tobacco, and therefore have the potential to lower the health risks of smoking, their potential value is lost when consumers do not accept these alternative propositions.
RRP Assessment: a Six Step Journey
We conduct our six-step approach referring to guidelines by public health authorities, such as the guidance document for industry on MRTP (Modified Risk Tobacco Products) Applications by US FDA. We conduct studies from chemical analysis of vapor to biological tests and clinical tests in order to scientifically prove the potential of risk reduction in individual users. In addition, we conduct surveys to monitor long-term effects and their impact on public health.
Our Reduced-Risk Products (RRP)* aim to meet both requirements, the potential to reduce the health risks associated with tobacco use and the ability to provide an acceptable user experience for consumers. We’re committed to bringing new and innovative RRP* to market, and are continually developing and testing them using scientifically rigorous methods.
